Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

Novo Nordisk (NVO) downgraded to Hold after FDA GLP-1 actions and 2026 patent cliffs threaten Wegovy supply and growth. See ...

On Friday, Novo Nordisk (NVO) shares saw an increase in pre-market trading. This market movement is directly linked to a new initiative by Amazon’s digital pharmacy. The platform announced it ...

According to an article posted by the Yale School of Medicine in July 2024, “The first drug in a class known as GLP-1 ...

With prices starting at $149 for cash-paying patients, the new Wegovy pill undercuts much of the current market.

The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral ...

The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...

The Food and Drug Administration approved the oral pill form of Wegovy, a GLP-1, last month. This week, Novo Nordisk said the ...

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...